Compounds for the treatment of marihuana dependence, withdrawal, and usage
The invention provides methods for treating or suppressing marihuana usage, withdrawal, or dependence involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, uridine-containing compound, creatine-containing compound, adenosine-containing, or adenosine-elevating compound to a mammal.
1. A method of ameliorating or suppressing marihuana dependence, withdrawal or usage, said method comprising administering to a human in need thereof a therapeutically-effective amount of a compound selected from the group consisting of a cytidine-containing compound, a cytosine-containing compound, and a creatine-containing compound.
2. The method of claim 1 , wherein said compound administered is cytidine.
3. The method of claim 1 , wherein said compound administered is said cytidine-containing compound further comprising choline.
4. The method of claim 1 , wherein said compound administered is CDP-choline.
5. The method of claim 4 , wherein said CDP-choline is administered orally.
6. The method of claim 1 , wherein said cytidine containing compound administered is CDP.
7. The method of claim 1 , wherein said administering is chronic.
8. The method of claim 1 , wherein said human is a child or adolescent.
9. The method of claim 1 , wherein said human is pregnant.
10. The method of claim 1 , further comprising administering a psychological intervention to said human.
11. The method of claim 1 , wherein craving is reduced.
12. The method of claim 1 , wherein said human is diagnosed with marihuana withdrawal or dependence.
13. A method of treating or suppressing marihuana dependence, withdrawal or usage, said method comprising administering to a human diagnosed with marihuana dependence, withdrawal or usage a therapeutically-effective amount of a compound selected from the group consisting of a cytidine-containing compound, a cytosine-containing compound, and a creatine-containing compound.
14. The method of claim 13 , wherein said compound administered is said cytidine-containing compound.
15. The method of claim 14 , wherein said compound administered is CDP-choline.
16. The method of claim 13 , further comprising administering a psychological intervention to said human.
17. The method of claim 13 , wherein said administering is chronic.
18. The method of claim 13 , wherein craving is reduced.
19. The method of claim 13 , wherein said human is diagnosed with marihuana withdrawal or dependence.